XBIO
XBIO
NASDAQ · Biotechnology

Xenetic Biosciences Inc

$2.08
+0.00 (+0.00%)
As of Feb 8, 2:32 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 996.2K 899.1K 945.5K
Net Income -293,752 -268,437 -236,795
EPS
Profit Margin -29.5% -29.9% -25.1%
Rev Growth -1.0% -1.1% +22.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 896.4K 814.0K 797.5K
Total Equity 2.97M 2.89M 2.95M
D/E Ratio 0.30 0.28 0.27
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -415,155 -429,552 -415,366
Free Cash Flow -272,222 -251,567 -250,593